Erythromycin and Panobinostat: Interaction Details
- Erythromycin
- Ery-cEry-tabPce +13 more
- Panobinostat
- Farydak
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Erythromycin and Panobinostat interaction:
Erythromycin
- Ery-c
- Ery-tab
- Pce
- Ees
- Pediamycin
- Emgel
- Erygel
- Theramycin
- Eyemycin
- EryPed
- Emcin Clear
- Ery
- E.e.s.
- Erythromycin Ethylsuccinate
- E.e.s
- E.e.s 400
Panobinostat
- Farydak
We don't have a drug information page for Panobinostat yet. Have a question about Panobinostat? Ask a pharmacist, free →
What Happens When You Take Erythromycin With Panobinostat
What can happen when they are taken together (rated Major)
Increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Because the effects on the may be , panobinostat should not be combined with drugs that prolong the QT interval. When use together with antiemetics known to prolong the QT interval cannot be avoided, ECGs should be monitored frequently.
Treatment should be interrupted if the Fridericia-corrected QT interval reaches 480 msecs or higher. If QT-interval prolongation persists once any electrolyte abnormalities have been corrected, panobinostat should be discontinued.1
The Erythromycin and Panobinostat Interaction, Explained
Both erythromycin (an antibiotic) and panobinostat (a cancer medicine) can affect the heart's electrical rhythm. Each can lengthen something called the , which is a part of the heartbeat cycle seen on an . Taken together, the effect on the heart rhythm could add up and raise the chance of a serious, irregular heartbeat. This is based on how the drugs work, not on a large number of reported cases, but it is still taken seriously.
Keep taking both as prescribed. Tell your pharmacist or doctor about every medicine you take. Your care team may check your heart with ECGs and review your blood salts (electrolytes), or they may choose a different antibiotic. Let them know right away if you feel faint, dizzy, or have a racing or fluttering heartbeat.
Mechanism: (). Erythromycin is a known risk drug for QT prolongation and . Panobinostat also prolongs . Erythromycin is also a , and panobinostat is partly CYP3A4-metabolized, so exposure may rise, but the documented concern here is QT. Neither drug is a that changes the direction of the interaction.
- Severity: major. Evidence: theoretical. Onset: unspecified.
- with QT-prolonging drugs is not recommended.
- If unavoidable, obtain frequent monitoring and correct electrolyte abnormalities.
- Interrupt panobinostat if QTcF is 480 msec or more. Discontinue if QT prolongation persists after electrolytes are corrected.
- Consider a non-QT-prolonging antibiotic alternative.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Erythromycin and Panobinostat Interact
The likely mechanism
How to Manage the Erythromycin and Panobinostat Interaction
Combining these is generally not recommended, so your care team will weigh whether you need both. Do not stop or change either medicine on your own.
- If both are needed, your team may check your heart with frequent ECGs.
- They may pause panobinostat if your gets too long (480 msec or more on the corrected measurement), and stop it if the problem does not clear once any electrolyte imbalances are fixed.
- They may consider a different antibiotic.
Tell your pharmacist or prescriber about any fainting, dizziness, or palpitations, and about any other medicines you take.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Erythromycin or Panobinostat need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Erythromycin and Panobinostat: Common Questions
How serious is the Erythromycin and Panobinostat interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Erythromycin and Panobinostat interaction managed?
Combining these is generally not recommended, so your care team will weigh whether you need both. Do not stop or change either medicine on your own. If both are needed, your team may check your heart with frequent ECGs. They may pause panobinostat if your gets too long (480 msec or more on the corrected measurement), and stop it if the problem does not clear once any electrolyte imbala… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Erythromycin and Panobinostat Interaction
Ask in your own words about taking Erythromycin and Panobinostat together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: FARYDAK(R) oral capsules, panobinostat oral capsules. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2015. DailyMed
Other Serious Interactions of Erythromycin and Panobinostat
Also serious with Erythromycin
- ColchicineContraindicated
- SimvastatinContraindicated
- AtorvastatinContraindicated
- Dihydroergotamine InjectionContraindicated
Also serious with Panobinostat
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Erythromycin
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- WineMajor
- American HelleboreMajor
- ArsenicMajor
- BeerMajor
- CesiumMajor
- + 201 more
With Panobinostat
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- + 150 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.